Eagle Wealth Strategies’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.92M Sell
4,105
-21
-0.5% -$21.5K 1.88% 7
2026
Q1
$3.8M Sell
4,126
-1
-0% -$1.01K 1.66% 9
2025
Q4
$4.44M Buy
4,127
+13
+0.3% +$12.4K 2.07% 8
2025
Q3
$3.14M Sell
4,114
-8
-0.2% -$5.95K 1.56% 11
2025
Q2
$3.21M Sell
4,122
-27
-0.7% -$21K 1.8% 10
2025
Q1
$3.43M Buy
4,149
+2
+0% +$1.66K 2.1% 9
2024
Q4
$3.2M Buy
4,147
+68
+2% +$56.3K 2.32% 6
2024
Q3
$3.61M Buy
4,079
+39
+1% +$35.1K 2.64% 4
2024
Q2
$3.66M Buy
4,040
+25
+0.6% +$20K 2.96% 4
2024
Q1
$3.05M Buy
4,015
+10
+0.2% +$7.12K 2.48% 5
2023
Q4
$2.33M Buy
+4,005
New +$2.34M 1.41% 9

Other funds holding LLY

Eagle Wealth Strategies's LLY Position: Q2 2026 in Review

Eagle Wealth Strategies reduced its Eli Lilly (LLY) stake by 0.51% in Q2 2026, selling an estimated $21.5K and leaving 4,105 shares worth $4.92M. The position accounts for 1.88% of the portfolio, ranked #7.

Eagle Wealth Strategies first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Eagle Wealth Strategies held 4,105 shares of Eli Lilly worth $4.92M as of Q2 2026.
  • Eagle Wealth Strategies sold 21 Eli Lilly shares in Q2 2026, an estimated $21.5K.
  • Eli Lilly made up 1.88% of Eagle Wealth Strategies's portfolio in Q2 2026, its #7 holding.
  • Eagle Wealth Strategies first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Eagle Wealth Strategies's 13F filing for Q2 2026, filed 9 Jul 2026.